Page 131 - 2022-36-中国全科医学

·4606· http://www.chinagp.net E-mail:zgqkyx@chinagp.net.cn

345-353. DOI：10.1093/aje/kww064. 10.1093/aje/kwy099.
［18］FUKUSHIMA W，HIROTA Y. Basic principles of test-negative ［29］DEAN N E，HOGAN J W，SCHNITZER M E. COVID-19 vaccine
design in evaluating influenza vaccine effectiveness［J］. effectiveness and the test-negative design［J］. N Engl J Med，
Vaccine，2017，35（36）：4796-4800. DOI：10.1016/j. 2021，385（15）：1431-1433. DOI：10.1056/NEJMe2113151.
vaccine.2017.07.003. ［30］KELLY H，JACOBY P，DIXON G A，et al. Vaccine effectiveness
［19］张力，金鹏飞，李靖欣，等 . 检测阴性设计在疫苗效果评价中 against laboratory-confirmed influenza in healthy young children：
的应用［J］. 中华流行病学杂志，2020，41（2）：280-283. a case-control study［J］. Pediatr Infect Dis J，2011，30（2）：
DOI：10.3760/cma.j.issn.0254-6450.2020.02.024. 107-111. DOI：10.1097/INF.0b013e318201811c.
ZHANG L，JIN P F，LI J X，et al. Application of test-negative ［31］NUNES B，MACHADO A，GUIOMAR R，et al. Estimates of
design in vaccine efficacy evaluation［J］. Chinese Journal of 2012/13 influenza vaccine effectiveness using the case test-negative
Epidemiology，2020，41（2）：280-283. DOI：10.3760/cma. control design with different influenza negative control groups［J］.
j.issn.0254-6450.2020.02.024. Vaccine，2014，32（35）：4443-4449. DOI：10.1016/j.
［20］SULLIVAN S G，FENG S，COWLING B J. Potential of the test- vaccine.2014.06.053.
negative design for measuring influenza vaccine effectiveness：a ［32］SUZUKI M，MINH L E N，YOSHIMINE H，et al. Vaccine
systematic review［J］. Expert Rev Vaccines，2014，13（12）： effectiveness against medically attended laboratory-confirmed
1571-1591. DOI：10.1586/14760584.2014.966695. influenza in Japan，2011-2012 Season［J］. PLoS One，2014，9
［21］JACKSON M L，ROTHMAN K J. Effects of imperfect test sensitivity （2）：e88813. DOI：10.1371/journal.pone.0088813.
and specificity on observational studies of influenza vaccine ［33］COWLING B J，NISHIURA H. Virus interference and
effectiveness［J］. Vaccine，2015，33（11）：1313-1316. estimates of influenza vaccine effectiveness from test-negative
DOI：10.1016/j.vaccine.2015.01.069. studies［J］. Epidemiology，2012，23（6）：930-931. DOI：
［22］ORENSTEIN E W，DE SERRES G，HABER M J，et al. 10.1097/EDE.0b013e31826b300e.
Methodologic issues regarding the use of three observational ［34］BLYTH C C，JACOBY P，EFFLER P V，et al. Effectiveness of
study designs to assess influenza vaccine effectiveness［J］. Int trivalent flu vaccine in healthy young children［J］. Pediatrics，
J Epidemiol，2007，36（3）：623-631. DOI：10.1093/ije/ 2014，133（5）：e1218-e1225. DOI：10.1542/peds.2013-3707.
dym021. ［35］SUNDARAM M E，MCCLURE D L，VANWORMER J J，et al.
［23］YU S T，THI BUI C，KIM D T H，et al. Clinical evaluation Influenza vaccination is not associated with detection of noninfluenza
of rapid fluorescent diagnostic immunochromatographic test for respiratory viruses in seasonal studies of influenza vaccine
influenza A virus （H1N1）［J］. Sci Rep，2018，8（1）： effectiveness［J］. Clin Infect Dis，2013，57（6）：789-793.
13468. DOI：10.1038/s41598-018-31786-8. DOI：10.1093/cid/cit379.
［24］MERCKX J，WALI R，SCHILLER I，et al. Diagnostic accuracy ［36］AINSLIE K E C，SHI M，HABER M，et al. On the bias of
of novel and traditional rapid tests for influenza infection compared estimates of influenza vaccine effectiveness from test-negative
with reverse transcriptase polymerase chain reaction：a systematic studies［J］. Vaccine，2017，35（52）：7297-7301. DOI：
review and meta-analysis［J］. Ann Intern Med，2017，167（6）： 10.1016/j.vaccine.2017.10.107.
394-409. DOI：10.7326/M17-0848. ［37］RID A，SAXENA A，BAQUI A H，et al. Placebo use in
［25］HIROTA Y，KAJI M. Principles and methods of influenza vaccine trials：recommendations of a WHO expert panel［J］.
epidemiology：with special reference to field evaluation of vaccine Vaccine，2014，32（37）：4708-4712. DOI：10.1016/j.
efficacy［J］. Kansenshogaku Zasshi，1994，68（11）：1293- vaccine.2014.04.022.
1305. DOI：10.11150/kansenshogakuzasshi1970.68.1293. ［38］BELONGIA E A，SIMPSON M D，KING J P，et al. Variable
［26］FELDSTEIN L R，SELF W H，FERDINANDS J M，et al. influenza vaccine effectiveness by subtype：a systematic review
Incorporating real-time influenza detection into the test-negative and meta-analysis of test-negative design studies［J］. Lancet
design for estimating influenza vaccine effectiveness：the real-time Infect Dis，2016，16（8）：942-951. DOI：10.1016/S1473-
test-negative design （rtTND）［J］. Clin Infect Dis，2021，72（9）： 3099(16)00129-8.
1669-1675. DOI：10.1093/cid/ciaa1453. ［39］WU S S，PAN Y，ZHANG X X，et al. Influenza vaccine
［27］JEWELL N P，DUFAULT S，CUTCHER Z，et al. Analysis effectiveness in preventing laboratory-confirmed influenza in
of cluster-randomized test-negative designs：cluster-level outpatient settings：a test-negative case-control study in Beijing，
methods［J］. Biostatistics，2019，20（2）：332-346. DOI： China，2016/17 season［J］. Vaccine，2018，36（38）：5774-
10.1093/biostatistics/kxy005. 5780. DOI：10.1016/j.vaccine.2018.07.077.
［28］ANDERS K L，CUTCHER Z，KLEINSCHMIDT I，et al. Cluster- ［40］VASILEIOU E，SHEIKH A，BUTLER C C，et al. Seasonal
randomized test-negative design trials：a novel and efficient method influenza vaccine effectiveness in people with asthma：a national
to assess the efficacy of community-level dengue interventions［J］. test-negative design case-control study［J］. Clin Infect Dis，
Am J Epidemiol，2018，187（9）：2021-2028. DOI： 2020，71（7）：e94-104. DOI：10.1093/cid/ciz1086.